Turnstone Biologics Corp.

NasdaqGM:TSBX Stock Report

Market Cap: US$11.5m

Turnstone Biologics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sammy Farah

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage47.3%
CEO tenure9.1yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure5.8yrs

Recent management updates

Recent updates

We're A Little Worried About Turnstone Biologics' (NASDAQ:TSBX) Cash Burn Rate

May 08
We're A Little Worried About Turnstone Biologics' (NASDAQ:TSBX) Cash Burn Rate

Here's Why We're A Bit Worried About Turnstone Biologics' (NASDAQ:TSBX) Cash Burn Situation

Jan 23
Here's Why We're A Bit Worried About Turnstone Biologics' (NASDAQ:TSBX) Cash Burn Situation

CEO Compensation Analysis

How has Sammy Farah's remuneration changed compared to Turnstone Biologics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$75m

Mar 31 2024n/an/a

-US$75m

Dec 31 2023US$1mUS$532k

-US$55m

Sep 30 2023n/an/a

-US$52m

Jun 30 2023n/an/a

-US$51m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$3mUS$501k

-US$31m

Compensation vs Market: Sammy's total compensation ($USD1.12M) is above average for companies of similar size in the US market ($USD655.65K).

Compensation vs Earnings: Sammy's compensation has been consistent with company performance over the past year.


CEO

Sammy Farah (51 yo)

9.1yrs

Tenure

US$1,123,756

Compensation

Dr. Sammy J. Farah, MBA, Ph D., serves as President, Chief Executive Officer & Director at Turnstone Biologics Corp. since October 2015. He serves as President and Chief Executive Officer at Turnstone Biol...


Leadership Team

NamePositionTenureCompensationOwnership
Sammy Farah
President9.1yrsUS$1.12mno data
Michael Burgess
Executive Director3.4yrsno data0%
$ 0
Wendy Worcester
Principal Financial & Accounting Officerless than a yearno datano data
Saryah Azmat
Chief Operating Officerless than a yearUS$1.06m0%
$ 0
David Stojdl
Senior Vice President of Research & Discoveryno datano datano data
Ines Verdon
Senior Vice President of Clinical Developmentless than a yearno datano data
Michael Fitch
Senior Vice President of Manufacturingless than a yearno datano data

0.5yrs

Average Tenure

51yo

Average Age

Experienced Management: TSBX's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Sammy Farah
President9.1yrsUS$1.12mno data
Michael Burgess
Executive Director3.4yrsno data0%
$ 0
William Waddill
Independent Directorless than a yearno datano data
Malcolm Brenner
Member of Scientific Advisory Boardno datano datano data
Bernard Fox
Member of the Scientific Advisory Boardno datano datano data
Rishi Gupta
Independent Director8.1yrsUS$77.73k0%
$ 0
Robert Gould
Independent Director5.8yrsUS$23.01k0%
$ 0
James Mule
Member of the Scientific Advisory Boardno datano datano data
Jerel Davis
Independent Chairman of the Board & Lead Independent Director9.1yrsUS$88.68k0%
$ 0
Kanya Rajangam
Independent Director3yrsUS$57.78k0%
$ 0
Adrian Hill
Member of the Scientific Advisory Boardno datano datano data
Alan Melcher
Member of the Scientific Advisory Boardno datano datano data

5.8yrs

Average Tenure

64yo

Average Age

Experienced Board: TSBX's board of directors are considered experienced (5.8 years average tenure).